| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $169.99B | +52.5% |
| Cost of Revenue | $149.93B | +46.8% |
| R&D Expense | $42.0M | -10.6% |
| SG&A Expense | $2.17B | +24.3% |
| Interest Expense | $619.0M | +6.5% |
| Income Tax | $3.25B | +2124.7% |
| Net Income | $11.02B | +737.1% |
| EPS (Basic) | $23.36 | +686.5% |
| EPS (Diluted) | $23.27 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.13B | +94.9% |
| Accounts Receivable | $10.98B | +47.1% |
| Inventory | $3.28B | -3.5% |
| Current Assets | $21.92B | +49.2% |
| Total Assets | $76.44B | +37.5% |
| Current Liabilities | $15.89B | +24.1% |
| Long-term Debt | $16.66B | +28.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.81B | +79.7% |
| Investing Cash Flow | -$1.49B | +20.5% |
| Financing Cash Flow | -$6.39B | -84.1% |
| +683.5% |
| Total Liabilities |
| $42.34B |
| +24.7% |
| Stockholders' Equity | $29.49B | +53.9% |